Published in J Pharmacol Exp Ther on September 01, 1986
Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice. Br J Pharmacol (2008) 1.46
Multiple sites of action of volatile anesthetics in Caenorhabditis elegans. Proc Natl Acad Sci U S A (1990) 1.42
Mutant mice lacking the gamma isoform of protein kinase C show decreased behavioral actions of ethanol and altered function of gamma-aminobutyrate type A receptors. Proc Natl Acad Sci U S A (1995) 1.34
Mapping quantitative trait loci mediating sensitivity to etomidate. Mamm Genome (2003) 0.80
The metabotropic glutamate receptor subtype 5 mediates sensitivity to the sedative properties of ethanol. Pharmacogenet Genomics (2010) 0.76
Sedative-hypnotic Effect of Ash of Silver in Mice: A Reverse Pharmacological Study. J Tradit Complement Med (2014) 0.75
Verapamil exerts biphasic modulation on phenobarbital transport across the blood-brain barrier: evidence from an in vivo and in vitro study. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.75
A method for fine mapping quantitative trait loci in outbred animal stocks. Proc Natl Acad Sci U S A (2000) 5.46
Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl) (1997) 5.03
Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice. Science (1992) 5.03
Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci U S A (1997) 3.26
International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev (1999) 2.76
High-resolution mapping of quantitative trait loci in outbred mice. Nat Genet (1999) 2.69
Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task. Behav Neurosci (1997) 2.65
VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc Natl Acad Sci U S A (1997) 2.34
Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor beta: evidence for tissue-specific modulation of receptor function. EMBO J (1996) 2.30
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci (1992) 2.29
A treatment for carpal tunnel syndrome: results of a follow-up study. J Manipulative Physiol Ther (1993) 2.08
A simple genetic basis for a complex psychological trait in laboratory mice. Science (1995) 2.06
Assessment of learning by the Morris water task and fear conditioning in inbred mouse strains and F1 hybrids: implications of genetic background for single gene mutations and quantitative trait loci analyses. Neuroscience (1997) 2.06
Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Ther (1983) 2.03
Effect of smoking history on [3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther (1997) 1.98
Why some people smoke and others do not: new perspectives. J Consult Clin Psychol (1993) 1.88
PKC gamma mutant mice exhibit mild deficits in spatial and contextual learning. Cell (1993) 1.84
Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice. Neuroscience (2003) 1.80
Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology (2000) 1.77
Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit. J Pharmacol Exp Ther (1999) 1.61
GABA(A)-receptor delta subunit knockout mice have multiple defects in behavioral responses to ethanol. Alcohol Clin Exp Res (2001) 1.59
Nicotine enhancement of contextual fear conditioning. Behav Brain Res (1999) 1.57
Quantitative trait loci analysis affecting contextual conditioning in mice. Nat Genet (1997) 1.54
Physical activity enhances spatial learning performance with an associated alteration in hippocampal protein kinase C activity in C57BL/6 and DBA/2 mice. Brain Res (1993) 1.50
125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain. Mol Pharmacol (2000) 1.46
Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum. J Neurochem (1992) 1.45
Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology (1996) 1.41
Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J Pharmacol Exp Ther (1985) 1.39
Point mutant mice with hypersensitive alpha 4 nicotinic receptors show dopaminergic deficits and increased anxiety. Proc Natl Acad Sci U S A (2001) 1.39
Defective motor behavior and neural gene expression in RIIbeta-protein kinase A mutant mice. J Neurosci (1998) 1.38
Mutant mice lacking the gamma isoform of protein kinase C show decreased behavioral actions of ethanol and altered function of gamma-aminobutyrate type A receptors. Proc Natl Acad Sci U S A (1995) 1.34
Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain. J Pharmacol Exp Ther (1998) 1.32
Differences between inbred strains of mice in Morris water maze performance. Behav Genet (1988) 1.32
Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine. Br J Pharmacol (2000) 1.31
The role of RNA editing of kainate receptors in synaptic plasticity and seizures. Neuron (2001) 1.28
Downregulation of nicotinic receptor function after chronic nicotine infusion. J Pharmacol Exp Ther (1993) 1.24
Inbred mouse strains vary in oral self-selection of nicotine. Psychopharmacology (Berl) (1996) 1.23
Genetic influences on nicotine responses. Pharmacol Biochem Behav (1989) 1.22
Perturbed dentate gyrus function in serotonin 5-HT2C receptor mutant mice. Proc Natl Acad Sci U S A (1998) 1.21
Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum. J Neurochem (2001) 1.21
High-resolution mapping of quantitative trait loci for emotionality in selected strains of mice. Mamm Genome (1999) 1.20
An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. J Pharmacol Exp Ther (1991) 1.19
Nicotine-induced tolerance and receptor changes in four mouse strains. J Pharmacol Exp Ther (1986) 1.19
Long sleep and short sleep mice differ in nicotine-stimulated 86Rb+ efflux and alpha4 nicotinic receptor subunit cDNA sequence. Pharmacogenetics (2001) 1.19
Unfolding of the host genome after infection of Escherichia coli with bacteriophage T4. J Virol (1974) 1.17
Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate. Mol Pharmacol (1982) 1.15
Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice. J Pharmacol Exp Ther (2007) 1.10
Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin. Mol Pharmacol (1986) 1.09
UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes. J Neurosci (2000) 1.09
Mutants of bacteriophage T4 deficient in the ability to induce nuclear disruption. II. Physiological state of the host nucleoid in infected cells. J Mol Biol (1974) 1.07
Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels. J Pharmacol Exp Ther (1996) 1.06
Ethanol consumption and behavioral impulsivity are increased in protein kinase Cgamma null mutant mice. J Neurosci (2001) 1.06
Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes. J Neurochem (1997) 1.05
Identification of quantitative trait loci involved in contextual and auditory-cued fear conditioning in BXD recombinant inbred strains. Behav Neurosci (1997) 1.05
Inbred mouse strains differ in the regulation of startle and prepulse inhibition of the startle response. Behav Neurosci (1997) 1.05
Age-related changes in neuronal nicotinic acetylcholine receptor subunit alpha4 expression are modified by long-term nicotine administration. J Neurosci (1998) 1.05
An autoradiographic analysis of cholinergic receptors in mouse brain. Brain Res Bull (1989) 1.03
An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain. Eur J Neurosci (1999) 1.03
Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. J Pharmacol Exp Ther (1998) 1.02
Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression. Brain Res Mol Brain Res (1999) 1.02
Nicotinic agonists differ in activation and desensitization of 86Rb+ efflux from mouse thalamic synaptosomes. J Pharmacol Exp Ther (1996) 1.02
Genotype influences the development of tolerance to nicotine in the mouse. J Pharmacol Exp Ther (1991) 1.02
Genetic correlation between performance on an appetitive-signaled nosepoke task and voluntary ethanol consumption. Alcohol Clin Exp Res (1998) 1.00
Enzymatic formation of zinc-protoporphyrin by rat liver and its potential effect on hepatic heme metabolism. Gastroenterology (1983) 1.00
Decreased ethanol sensitivity and tolerance development in gamma-protein kinase C null mutant mice is dependent on genetic background. Alcohol Clin Exp Res (1999) 1.00
Genetic influence upon phenobarbital-induced increase in rat liver supernatant aldehyde dehydrogenase activity. J Biol Chem (1972) 0.98
Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes. J Neurochem (1994) 0.98
Prenatal nicotine alters nicotinic receptor development in the mouse brain. Pharmacol Biochem Behav (1994) 0.97
Alpha7-nicotinic receptor expression and the anatomical organization of hippocampal interneurons. Brain Res (2001) 0.97
Effects of aging on spatial learning and hippocampal protein kinase C in mice. Neurobiol Aging (1993) 0.97
Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes. J Pharmacol Exp Ther (1993) 0.97
Role of liver cytosolic aldehyde dehydrogenase isozymes in control of blood acetaldehyde concentrations. J Pharmacol Exp Ther (1977) 0.96
Developmental differences in place-learning performance between C57BL/6 and DBA/2 mice parallel the ontogeny of hippocampal protein kinase C. Behav Neurosci (1996) 0.95
Behavioral assessment of c-fos mutant mice. Brain Res (1994) 0.95
Genetics of nicotine response in four inbred strains of mice. J Pharmacol Exp Ther (1983) 0.94
Chromosomal assignment of the gene for the human beta 2-adrenergic receptor. Proc Natl Acad Sci U S A (1983) 0.94
Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice. Brain Res (2007) 0.94
Nicotinic-agonist stimulated (86)Rb(+) efflux and [(3)H]epibatidine binding of mice differing in beta2 genotype. Neuropharmacology (2000) 0.94
Strain comparison of nicotine-induced seizure sensitivity and nicotinic receptors. Pharmacol Biochem Behav (1989) 0.93
Knockout mice and dirty drugs. Drug addiction. Curr Biol (1996) 0.93
Comparative bladder tumor promoting activity of sodium saccharin, sodium ascorbate, related acids, and calcium salts in rats. Cancer Res (1991) 0.93
Variation of nicotinic binding sites among inbred strains. Pharmacol Biochem Behav (1989) 0.93
Pharmacological comparison of transient and persistent [3H]dopamine release from mouse striatal synaptosomes and response to chronic L-nicotine treatment. J Pharmacol Exp Ther (1997) 0.92
Pharmacological and null mutation approaches reveal nicotinic receptor diversity. Eur J Pharmacol (2000) 0.92
RJR-2403: a nicotinic agonist with CNS selectivity II. In vivo characterization. J Pharmacol Exp Ther (1996) 0.92
Postnatal development of cholinergic enzymes and receptors in mouse brain. J Neurochem (1987) 0.91
Mice lacking PKC gamma exhibit decreased anxiety. Behav Genet (2000) 0.91
Protein and molecular characterization of hippocampal protein kinase C in C57BL/6 and DBA/2 mice. J Neurochem (1995) 0.91
The influence of genotype and sex on behavioral sensitivity to nicotine in mice. Psychopharmacology (Berl) (1980) 0.91
Effects of N-methyl-D-aspartate antagonism on spatial learning in mice. Psychopharmacology (Berl) (1990) 0.90
Desensitization of nicotinic agonist-induced [3H]gamma-aminobutyric acid release from mouse brain synaptosomes is produced by subactivating concentrations of agonists. J Pharmacol Exp Ther (1999) 0.90
Plasma concentrations of carotenoids and antioxidant vitamins in Scottish males: influences of smoking. Eur J Clin Nutr (1995) 0.89
Alpha calcium/calmodulin kinase II mutant mice: deficient long-term potentiation and impaired spatial learning. Cold Spring Harb Symp Quant Biol (1992) 0.89
Brief exposure to an enriched environment improves performance on the Morris water task and increases hippocampal cytosolic protein kinase C activity in young rats. Behav Brain Res (1992) 0.89